Laurie A.  Miller net worth and biography

Laurie Miller Biography and Net Worth

SVP of Haemonetics
Laurie Miller was appointed Senior Vice President of Human Resources and Chief Human Resources Officer in August 2021. Since joining Haemonetics in 2016, she has held a variety of leadership roles within its Human Resources organization to help build the company’s collaborative, performance-based culture, direct key employee-focused initiatives and create a strong workplace environment for Haemonetics teams worldwide. Her global talent management expertise has driven the company’s commitment to excellence in training, benefits, recruitment, communications and more. Laurie brings over 25 years of experience in talent management and organizational development, having held a variety of leadership positions with prominent organizations including Iron Mountain, Dunkin’ Brands and Shawmut Design and Construction. She holds a Bachelor of Science, Business Management from Westfield State College and a Master of Science, Management from Emmanuel College.

What is Laurie A. Miller's net worth?

The estimated net worth of Laurie A. Miller is at least $1.13 million as of September 19th, 2022. Ms. Miller owns 12,697 shares of Haemonetics stock worth more than $1,132,826 as of November 18th. This net worth evaluation does not reflect any other assets that Ms. Miller may own. Learn More about Laurie A. Miller's net worth.

How old is Laurie A. Miller?

Ms. Miller is currently 51 years old. There are 5 older executives and no younger executives at Haemonetics. The oldest executive at Haemonetics is Mr. Josep Lluis Llorens, Executive Vice President of Global Manufacturing & Supply Chain, who is 62 years old. Learn More on Laurie A. Miller's age.

How do I contact Laurie A. Miller?

The corporate mailing address for Ms. Miller and other Haemonetics executives is 125 Summer Street, Boston MA, 02110. Haemonetics can also be reached via phone at (781) 848-7100 and via email at [email protected]. Learn More on Laurie A. Miller's contact information.

Has Laurie A. Miller been buying or selling shares of Haemonetics?

Laurie A. Miller has not been actively trading shares of Haemonetics in the last ninety days. Most recently, Laurie A. Miller sold 212 shares of the business's stock in a transaction on Monday, September 19th. The shares were sold at an average price of $76.25, for a transaction totalling $16,165.00. Following the completion of the sale, the senior vice president now directly owns 12,697 shares of the company's stock, valued at $968,146.25. Learn More on Laurie A. Miller's trading history.

Who are Haemonetics' active insiders?

Haemonetics' insider roster includes Michelle Basil (EVP), William Burke (CFO), Dan Goldstein (VP), Mark Kroll (Director), Anila Lingamneni (EVP), Josep Llorens (EVP), Richard Meelia (Director), Laurie Miller (SVP), Jacqueline Scanlan (SVP), Christopher Simon (CEO), and Stewart Strong (Insider). Learn More on Haemonetics' active insiders.

Are insiders buying or selling shares of Haemonetics?

During the last twelve months, insiders at the medical instruments supplier sold shares 9 times. They sold a total of 33,828 shares worth more than $3,031,094.99. The most recent insider tranaction occured on July, 26th when insider Stewart W Strong sold 4,312 shares worth more than $393,038.80. Insiders at Haemonetics own 1.8% of the company. Learn More about insider trades at Haemonetics.

Information on this page was last updated on 7/26/2024.

Laurie A. Miller Insider Trading History at Haemonetics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/19/2022Sell212$76.25$16,165.0012,697View SEC Filing Icon  
7/5/2022Sell42$66.18$2,779.5612,909View SEC Filing Icon  
6/13/2022Sell30$62.60$1,878.0012,951View SEC Filing Icon  
6/2/2022Sell198$62.69$12,412.6212,981View SEC Filing Icon  
5/19/2022Sell91$59.10$5,378.1013,179View SEC Filing Icon  
5/16/2022Sell31$56.10$1,739.1010,232View SEC Filing Icon  
See Full Table

Laurie A. Miller Buying and Selling Activity at Haemonetics

This chart shows Laurie A Miller's buying and selling at Haemonetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Haemonetics Company Overview

Haemonetics logo
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $89.22
Low: $88.64
High: $91.43

50 Day Range

MA: $77.55
Low: $71.15
High: $93.38

2 Week Range

Now: $89.22
Low: $70.25
High: $97.97

Volume

564,400 shs

Average Volume

555,780 shs

Market Capitalization

$4.48 billion

P/E Ratio

37.02

Dividend Yield

N/A

Beta

0.32